Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Navigating CAR-T cells through the solid-tumour microenvironment
Andrew J. Hou, Laurence C. Chen, Yvonne Y. Chen
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 7, pp. 531-550
Open Access | Times Cited: 366

Showing 1-25 of 366 citing articles:

Clinical implications of T cell exhaustion for cancer immunotherapy
Andrew Chow, Karlo Perica, Christopher A. Klebanoff, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 12, pp. 775-790
Open Access | Times Cited: 492
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy
Kevin Pan, Hizra Farrukh, Veera Chandra Sekhar Reddy Chittepu, et al.
Journal of Experimental & Clinical Cancer Research (2022) Vol. 41, Iss. 1
Open Access | Times Cited: 401
Engineered CAR-Macrophages as Adoptive Immunotherapies for Solid Tumors
Christopher Sloas, Saar Gill, Michael Klichinsky
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 151
CAR T cell therapy and the tumor microenvironment: Current challenges and opportunities
Lionel Aurelien Kankeu Fonkoua, Olivia Sirpilla, Reona Sakemura, et al.
Molecular Therapy — Oncolytics (2022) Vol. 25, pp. 69-77
Open Access | Times Cited: 143
Heterogeneity of the tumor immune microenvironment and its clinical relevance
Qingzhu Jia, Aoyun Wang, Yixiao Yuan, et al.
Experimental Hematology and Oncology (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 122
Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity
Leyuan Ma, Alexander Hostetler, Duncan M. Morgan, et al.
Cell (2023) Vol. 186, Iss. 15, pp. 3148-3165.e20
Open Access | Times Cited: 89
Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors
Zebin Xiao, Leslie Todd, Li Huang, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 88
Glypican-3: A Novel and Promising Target for the Treatment of Hepatocellular Carcinoma
Xiufeng Zheng, Xun Liu, Yanna Lei, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 83
IL-10-expressing CAR T cells resist dysfunction and mediate durable clearance of solid tumors and metastases
Yang Zhao, Jiangqing Chen, Massimo Andreatta, et al.
Nature Biotechnology (2024) Vol. 42, Iss. 11, pp. 1693-1704
Closed Access | Times Cited: 83
The Notch signaling pathway: a potential target for cancer immunotherapy
Xinxin Li, Xianchun Yan, Yufeng Wang, et al.
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 79
Safety and antitumor activity of GD2-Specific 4SCAR-T cells in patients with glioblastoma
Zhuohao Liu, Jiayi Zhou, Xinzhi Yang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 76
Recent Advances and Challenges in Cancer Immunotherapy
Chelsea Peterson, Nathan Denlinger, Yiping Yang
Cancers (2022) Vol. 14, Iss. 16, pp. 3972-3972
Open Access | Times Cited: 74
Advancing CAR T cell therapy through the use of multidimensional omics data
Jingwen Yang, Yamei Chen, Ying Jing, et al.
Nature Reviews Clinical Oncology (2023) Vol. 20, Iss. 4, pp. 211-228
Closed Access | Times Cited: 65
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial
Stephen Bagley, Zev A. Binder, Lamia Lamrani, et al.
Nature Cancer (2024)
Open Access | Times Cited: 62
CAR-T cell manufacturing: Major process parameters and next-generation strategies
Melanie Ayala Ceja, Mobina Khericha, Caitlin Harris, et al.
The Journal of Experimental Medicine (2024) Vol. 221, Iss. 2
Open Access | Times Cited: 62
Successes and challenges in clinical gene therapy
Donald B. Kohn, Yvonne Y. Chen, Melissa J. Spencer
Gene Therapy (2023) Vol. 30, Iss. 10-11, pp. 738-746
Open Access | Times Cited: 60
Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy
Marcel P. Trefny, Nicole Kirchhammer, Priska Auf der Maur, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 45
Adoptive cell therapy for cancer treatment
Shi Du, Jinyue Yan, Yonger Xue, et al.
Exploration (2023) Vol. 3, Iss. 4
Open Access | Times Cited: 44
Non-invasive activation of intratumoural gene editing for improved adoptive T-cell therapy in solid tumours
Xiaohong Chen, Shuang Wang, Yuxuan Chen, et al.
Nature Nanotechnology (2023) Vol. 18, Iss. 8, pp. 933-944
Closed Access | Times Cited: 41
Osr2 functions as a biomechanical checkpoint to aggravate CD8+ T cell exhaustion in tumor
Jinjia Zhang, Junhong Li, Yongqiang Hou, et al.
Cell (2024) Vol. 187, Iss. 13, pp. 3409-3426.e24
Closed Access | Times Cited: 39
Naturally occurring T cell mutations enhance engineered T cell therapies
Julie Garcia, Jay Daniels, Yujin Lee, et al.
Nature (2024) Vol. 626, Iss. 7999, pp. 626-634
Closed Access | Times Cited: 36
Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapy
Judith Wienke, Lindy L. Visser, Waleed M. Kholosy, et al.
Cancer Cell (2024)
Open Access | Times Cited: 32
Current challenges and therapeutic advances of CAR-T cell therapy for solid tumors
T. R. Chen, Mingzhao Wang, Yanchao Chen, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 29
IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and cancer-associated fibroblasts
Astrid Van den Eynde, Laura Gehrcken, Tias Verhezen, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 27
Evolution of cell therapy for renal cell carcinoma
Yufei Wang, Eloah Rabello Suarez, Gabriella Kastrunes, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top